A New Era in Bladder Cancer Treatment: Targeted Therapy Offers Hope – Daniel Chong, MD, Virginia Cancer Specialists

  Bladder cancer, though not as widely discussed as some other cancers, is a significant health concern worldwide. With approximately 82,000 new cases each year, and sadly, 16,700 annual deaths attributed to it, it demands attention and innovative solutions. Fortunately, advancements in medical science have led to a greater understanding of bladder cancer and improved […]

Redefining Cancer Treatment With Personalized Medicine and Early Intervention – Geoffrey Moorer, MD

Trends in the treatment for patients with cancer are shifting towards earlier intervention, with effective therapies like immunotherapy moving into neoadjuvant stages for improved outcomes. However, Geoffrey D. Moorer, MD, believes that challenges remain in ensuring wider access to sequencing and overcoming data complexity. While the future holds immense potential for artificial intelligence to revolutionize […]

Brentuximab Vedotin: A Promising Frontline Therapy for Older Hodgkin Lymphoma Patients

A recent study published by Dr. Dipti Patel-Donnelly, of Virginia Cancer Specialists and colleagues has shed light on a groundbreaking approach in the treatment of advanced-stage classical Hodgkin lymphoma (cHL) in older patients. This noncomparative phase 2 study, detailed in the research article here, explores the efficacy of brentuximab vedotin (BV) in combination with dacarbazine […]

Enhancing Lung Cancer Treatment: The Promise of Perioperative Immunotherapy – Samantha DiBenedetto, MD

Introduction: Lung cancer remains one of the most challenging and life-threatening diseases; however, several exciting treatment advances show promising benefits. A recent study in which Virginia Cancer Specialists participated under the research leadership of Dr. Alex Spira, the AEGEAN trial, was published in the New England Journal of Medicine (NEJM) earlier this month and has shed light […]

New Advances in Early-Stage Lung Cancer Treatment – Samantha DiBenedetto, MD

Lung cancer poses a significant healthcare challenge in the United States, with approximately 237,000 individuals newly diagnosed each year. Although the majority of cases are found at an advanced stage, approximately 25-35% of cases are detected early where surgery and chemotherapy can be effective treatment options. Despite these efforts, disease recurrence rates remain high, impacting […]